Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial
Go back to Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial| Pfizer Inc. (NYSE: PFE) | Delayed: 28.07 -0.17 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.24 | 52 Week High | $37.39 | |||
| Open | $28.00 | 52 Week Low | $28.25 | |||
| Day High | $28.16 | P/E | 17.01 | |||
| Day Low | $27.65 | EPS | $1.65 | |||
| Volume | 14,943,176 | |||||

